AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elanix Biotechnologies AG

Declaration of Voting Results & Voting Rights Announcements Mar 9, 2017

136_dva_2017-03-09_43e36232-6b12-4b28-9f0c-e5c7f7da5d57.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Total Voting Rights | 9 March 2017 17:40

Elanix Biotechnologies AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elanix Biotechnologies AG / Total Voting Rights Announcement

09.03.2017 / 17:40

Total Voting Rights Announcement according to Article 26a of the WpHG transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuerElanix Biotechnologies AG

Domstr. 22

14482 Potsdam

Germany

2. Type of capital measure

Type of capital measure Date of status / date of effect
Conditional capital increase (Sec. 26a para. 2 WpHG)
X Other capital measure (Sec. 26a para. 1 WpHG) 09 March 2017

3. New total number of voting rights:****6.799.200


09.03.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: Elanix Biotechnologies AG
Domstr. 22
14482 Potsdam
Germany
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.